Sectors

LPCN
Lipocine Inc.
2.23
1 x 2.19
2 x 2.23
bid
ask
+
0.04
1.83%
04:00 PM
timesize
Ytd-72.23%
1y-31.60%
2.23
day range
2.24
1.81
52 week range
12.37
Open2.23Prev Close2.19Low2.23High2.24Mkt Cap12.71M
Vol895.00Avg Vol95.09KEPS-1.88P/E-1.16Forward P/E-3.87
Beta0.44Short Ratio2.80Inst. Own9.96%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning08-1450-d Avg2.30200-d Avg4.631yr Est21.50
Income Statement
Total Revenue119.40K
Revenues (USD)119.40K
Gross Profit119.40K
Operating Expenses3.97M
Research and Development Expense2.76M
Selling, General and Administrative Expense1.20M
Operating Income-3.85M
Net Income-3.67M
Net Income Common Stock-3.67M
Net Income Common Stock (USD)-3.67M
Consolidated Income-3.67M
Earnings per Basic Share-0.54
Earnings per Basic Share (USD)-0.54
Earnings per Diluted Share-0.54
Earning Before Interest & Taxes (EBIT)-3.67M
Earning Before Interest & Taxes (USD)-3.67M
Weighted Average Shares6.80M
Weighted Average Shares Diluted6.80M
Balance Sheet
Cash and Equivalents5.02M
Cash and Equivalents (USD)5.02M
Investments19.71M
Investments Current19.71M
Trade and Non-Trade Receivables119.40K
Current Assets25.24M
Property, Plant & Equipment Net89.48K
Total Assets25.36M
Current Liabilities2.53M
Total Liabilities2.53M
Accumulated Retained Earnings (Deficit)-213.07M
Accumulated Other Comprehensive Income-7.19K
Shareholders Equity22.83M
Shareholders Equity (USD)22.83M
Assets Non-Current113.23K
Deferred Revenue320.00K
Trade and Non-Trade Payables1.56M
Cash Flow
Depreciation, Amortization & Accretion14.81K
Net Cash Flow from Financing11.97M
Net Cash Flow / Change in Cash & Cash Equivalents-190.23K
Issuance (Purchase) of Equity Shares11.97M
Net Cash Flow from Investing-9.90M
Net Cash Flow - Investment Acquisitions and Disposals-9.90M
Net Cash Flow from Operations-2.26M
Share Based Compensation65.40K